Compound Profiles
HGH Fragment 176-191
Growth Hormone Fragment | Fat Loss Peptide
Mimics the lipolytic region of human growth hormone by stimulating fat breakdown through beta-3 adrenergic receptor pathways. Unlike full HGH, it does not bind the growth hormone receptor, so it does not increase IGF-1 levels or interfere with glucose metabolism.
MK-677
Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue
Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take HGH Fragment 176-191 with MK-677?
Yes, but with caution. Both HGH Fragment 176-191 and MK-677 affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.
Is HGH Fragment 176-191 and MK-677 safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between HGH Fragment 176-191 and MK-677?
Both HGH Fragment 176-191 and MK-677 affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.
How should I time HGH Fragment 176-191 and MK-677?
HGH Fragment 176-191 has a half-life of 15-20 minutes and MK-677 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.